Medtronic gains FDA nod for artificial pancreas device

09/30/2013 | Star Tribune (Minneapolis-St. Paul, Minn.)

The FDA has granted Medtronic approval for what the company says is the first artificial pancreas device that stops insulin delivery automatically when the patient's blood sugar falls to preset levels. The MiniMed 530G with Enlite system, designed for diabetes patients 16 years or older, will be available commercially in the next few weeks.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC